Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013716
Filing Date
2019-11-07
Accepted
2019-11-07 17:16:06
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort9301910-qdoc.htm   iXBRL 10-Q 1040394
2 EXHIBIT 31.1 cort93019ex311.htm EX-31.1 11483
3 EXHIBIT 31.2 cort93019ex312.htm EX-31.2 11467
4 EXHIBIT 32.1 cort93019ex321.htm EX-32.1 5783
5 EXHIBIT 32.2 cort93019ex322.htm EX-32.2 5649
  Complete submission text file 0001628280-19-013716.txt   4202029

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20190930.xsd EX-101.SCH 26811
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20190930_cal.xml EX-101.CAL 65398
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20190930_def.xml EX-101.DEF 89780
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20190930_lab.xml EX-101.LAB 380898
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20190930_pre.xml EX-101.PRE 206959
37 EXTRACTED XBRL INSTANCE DOCUMENT cort9301910-qdoc_htm.xml XML 670530
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 191201319
SIC: 2834 Pharmaceutical Preparations